Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Moleculin Biotech, Inc. | 164,001 | reported | 12 Nov 2025 | tx 6+220,000 |
| Checkmate Pharmaceuticals, Inc. | 0 | reported | 31 May 2022 | tx 2+20,061−20,061 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Nov 2025 | GRANT_AWARD | Moleculin Biotech, Inc. | 150,000 | — | deriv |
| 04 Nov 2024 | GRANT_AWARD | Moleculin Biotech, Inc. | 10,000 | — | deriv |
| 25 May 2023 | GRANT_AWARD | Moleculin Biotech, Inc. | 15,000 | — | deriv |
| 20 Jun 2022 | GRANT_AWARD | Moleculin Biotech, Inc. | 23,333 | — | deriv |
| 20 Jun 2022 | GRANT_AWARD | Moleculin Biotech, Inc. | 15,000 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 20,061 | — | deriv |
| 01 Mar 2022 | GRANT_AWARD | Moleculin Biotech, Inc. | 6,667 | — | deriv |
| 16 Dec 2021 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 20,061 | 0.00 USD | deriv |